We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

9987:HKEXYum China Holdings, Inc. Analysis

Data as of 2026-08-08 - not real-time

HK$379.20

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

At HKD 379.20, Yum China Holdings, Inc. shows no decisive moving-average alignment, leaving the trend neutral. Across the trailing 30 sessions it gained 18.6%. RSI sits at 66.0, which reads as approaching overbought, and MACD momentum is bullish. Price has been bracketed by support at HKD 330.60 and resistance at HKD 393.60.
The shares look fair at 17.7 times earnings, though no sector average was available for comparison. Analyst price targets sit 26.7% above the current price. Revenue is growing at 12.6% on a 7.8% profit margin. The 2.40% dividend yield looks covered by current payout levels.
The composite risk read is 4/10, putting it in moderate territory. With 30-day volatility of 29.9%, a beta of -0.02 and a maximum drawdown of 29.7%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on buy — conviction 6 out of 10.

Top Market Events

Yum China Holdings, Inc. NYSE: YUMC and HKEX: 9987, "Yum China" or the "Company" today announced, in compliance with...SHANGHAI, June 16, 2026 /PRNewswire/ -- Yum China Holdings, Inc.SHANGHAI, June 16, 2026 /PRNewswire/ -- Yum China Holdings, Inc.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Trading above the 200-day average of 371.76
  • MACD momentum is positive
  • 30-day price change of +18.6%

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Trading above the 200-day average of 371.76
  • Analyst targets imply +26.7% versus the current price
  • MACD momentum is positive

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Analyst targets imply +26.7% versus the current price
  • Revenue growth of +12.6%
  • P/E ratio of 17.7

Key Metrics & Analysis

Financial Health

Revenue Growth12.60%
Profit Margin7.84%
P/E Ratio17.7
ROE16.81%
ROA8.08%
Debt/Equity30.74
P/B Ratio3.1
Op. Cash FlowHK$1.6B
Free Cash FlowHK$1.3B

Technical Analysis

TrendNeutral
RSI66.0
SupportHK$330.60
ResistanceHK$393.60
MA 20HK$357.93
MA 50HK$343.57
MA 200HK$371.76
MACDBullish
VolumeIncreasing
Fear & Greed Index94.82

Valuation

Fair ValueHK$79.33
Target PriceHK$480.44
Upside/Downside26.70%
GradeFair
TypeBlend
Dividend Yield2.40%

Risk Assessment

Beta-0.02
Volatility29.91%
Sector RiskHigh
Reg. RiskLow
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.